首页> 美国卫生研究院文献>Oncotarget >Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis
【2h】

Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis

机译:淀粉样前体样蛋白2(APLP2)影响肌动蛋白细胞骨架并增加胰腺癌的生长和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Amyloid precursor-like protein 2 (APLP2) is aberrantly expressed in pancreatic cancer. Here we showed that APLP2 is increased in pancreatic cancer metastases, particularly in metastatic lesions found in the diaphragm and intestine. Examination of matched human primary tumor-liver metastasis pairs showed that 38.1% of the patients had positive APLP2 expression in both the primary tumor and the corresponding liver metastasis. Stable knock-down of APLP2 expression (with inducible shRNA) in pancreatic cancer cells reduced the ability of these cells to migrate and invade. Loss of APLP2 decreased cortical actin and increased intracellular actin filaments in pancreatic cancer cells. Down-regulation of APLP2 decreased the weight and metastasis of orthotopically transplanted pancreatic tumors in nude mice.
机译:淀粉样前体样蛋白2(APLP2)在胰腺癌中异常表达。在这里,我们显示了APLP2在胰腺癌转移中增加,特别是在diaphragm肌和肠道中发现的转移性病变中增加。对匹配的人类原发性肿瘤-肝转移对的检查显示,有38.1%的患者在原发性肿瘤和相应的肝转移中均具有阳性APLP2表达。胰腺癌细胞中APLP2表达的稳定敲低(具有可诱导的shRNA)降低了这些细胞迁移和侵袭的能力。 APLP2的丢失会降低胰腺癌细胞中的皮质肌动蛋白并增加细胞内肌动蛋白丝。 APLP2的下调减少了裸鼠原位移植胰腺肿瘤的重量和转移。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号